-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

731.Oral1.6 731. Clinical Autologous Transplantation: Results: Novel Conditioning & Maintenance Approaches

Clinical Autologous Transplantation: Results Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Diseases, multiple myeloma, Biological, Adult, smoldering myeloma, Therapies, Non-Biological, chemotherapy, Study Population, Lymphoid Malignancies, Clinically relevant, Plasma Cell Disorders, stem cells
Sunday, December 10, 2017: 9:30 AM-11:00 AM
Bldg C, Lvl 1, C101 Aud (Georgia World Congress Center)
Moderators:
Parameswaran Hari, MBBS, MD, Medical College of Wisconsin and Muzaffar H. Qazilbash, MD , UT M.D. Anderson Cancer Ctr.
Disclosures:
Hari: Takeda: Consultancy; Celgene: Consultancy; Amgen: Consultancy; Takeda: Research Funding. Qazilbash: Merck: Honoraria; Otsuka: Research Funding.
9:30 AM

Michele Cavo, MD1*, Roman Hájek, MD2, Lucia Pantani, MD1*, Meral Beksac, MD3, Stefania Oliva, MD4*, Luca Dozza1*, Hans Erik Johnsen, MD, Professor5, Maria Teresa Petrucci, MD6*, Ulf-Henrik Mellqvist, MD7, Concetta Conticello, MD8*, Christoph Driessen, MD9, Giulia Marzocchi, BSc1*, Meletios A. Dimopoulos10, Sonja Zweegman, MD11, Ka Lung Wu, MD12*, Barbara Gamberi, MD13*, Claudia Crippa, MD14*, Bronno van der Holt15*, Massimo Offidani, MD16, Ruth Wester17*, Iolanda Donatella Vincelli, MD18*, Rossella Troia4*, Petra Cornelisse19*, Mario Boccadoro, MD4* and Pieter Sonneveld, MD, PhD20

1Seragnoli Institute of Hematology, Bologna University School of Medicine, Bologna, Italy
2Faculty of Medicine, Department of Pathological Physiology, Babak Myeloma Group, Masaryk University, Brno, Czech Republic
3Ankara University School of Medicine Department of Hematology, Ankara, Turkey
4Myeloma Unit, Division of Hematology, University of Torino, Torino, Italy
5Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark
6Department of Hematology, Sapienza University of Rome, Roma, Italy
7Department of Hematology, Borås Hospital, Borås, Sweden
8University of Catania, Division of Hematology, Azienda Policlinico-OUE, Catania, Italy
9Klinik für Onkologie und Hämatologie, Kantonsspital St.Gallen, St.Gallen, Switzerland
10National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
11Department of Hematology, VUMC, Amsterdam, Netherlands
12Department of Hematology, ZNA Stuivenberg,, Antwerpen, Belgium
13Hematology Unit, Azienda Ospedaliera ASMN, IRCCS, Reggio Emilia, Reggio Emilia, Italy
14Hematology, Spedali Civili, Brescia, ITA
15Department of Hematology, HOVON Data Center, Erasmuc MC Cancer Institute, Rotterdam, Netherlands
16Hematology, AOU Ospedali Riuniti di Ancona, Ancona, Italy
17Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands
18Azienda Ospedaliera Bianchi-Melacrino-Morelli, Reggio Calabria, Reggio Calabria, Italy
19Erasmus MC Cancer Institute-Clinical Trial Center, HOVON Data Center, Rotterdam, Netherlands
20Erasmus Medical Center Rotterdam, Rotterdam, Netherlands

9:45 AM

Murielle Roussel1*, Benjamin Hebraud, MD1*, Valerie Lauwers-Cances, MD2*, Margaret Macro, MD3*, Xavier Leleu, MD, PhD4, Cyrille Hulin, MD5*, Lionel Karlin, MD6*, Bruno Royer, MD7*, Aurore Perrot, MD8*, Philippe Moreau9*, Denis Caillot, MD10*, Sophie Rigaudeau, MD11*, Mamoun Dib, MD12*, Emmanuelle Nicolas-Virelizier, MD13*, Martine Escoffre-Barbe, MD14*, Karim Belhadj, MD15*, Brigitte Pegourie, MD16*, Anne-Marie Stoppa, MD17, Carla Araujo, MD18*, Chantal Doyen, MD19, Jean Fontan, MD20*, Brigitte Kolb, MD21*, Laurent Garderet, MD, PhD22, Sabine Brechignac, MD23*, Jean Valere Malfuson, MD24*, Veronique Dorvaux, MD25*, Pascal Lenain, MD26*, Omar Benbrahim, MD27*, Arnaud Jaccard28*, Cecile Borel, MD1*, Herve Avet Loiseau, MD, PhD29 and Michel Attal, MD, PhD30

1Hematology Department, IUCT-Oncopole, Toulouse, France
2USMR, service d'Epidemiologie, CHU Toulouse, TOULOUSE, France
3Haematology Department, Caen University Hospital, Caen, France
4Hematology, Department of Oncology-Haematology and Cell Therapy, CHU, Poitiers, INSERM, Inserm CIC 1402, Poitiers, France, Poitiers, France
5Hopital Haut leveque CHU, bordeaux, France
6Ch Lyon Sud, Pierre Bénite, France
7Department of Hematology, University Hospital, Amiens, France
8Hôpitaux De Brabois, Vandoeuvre Les Nancy, France
9Clinical Hematology, Nantes University Hospital, Nantes, France
10Department of Hematology, University Hospital of Dijon, Dijon, France
11Service Hematologie, CHU Andre Mignot, Versailles, France
12Hématologie - CHU - Hôpital du Bocage, Angers, France
13Onco-hematology, Centre Leon Berard, University Claude Bernard Lyon 1, Lyon, France
14Hematology, University Hospital CHU Rennes, Rennes, France
15CHU Henri Mondor, Creteil, France
16Hôpital A.Michallon, CHU Grenoble, Grenoble, France
17Institut J Paoli-Calmettes, Marseille, France
18Centre Hospitalier de la côte basque, Bayonne, France
19Cliniques Universitaires UCL Mont-Godinne, Yvoir, BEL
20Service Hematologie, Hôpital Jean Minjoz, Besancon, France
21Hopital Robert Debre, Reims Cedex, France
22Service d’Hématologie et Thérapie Cellulaire, Hopital Saint Antoine, Paris, France
23Hématologie, HOPITAL AVICENNE, Bobigny, France
24Hôpital d'instruction des armées Percy, Paris Cedex 10, FRA
25Medecine Interne, Hopital Notre Dame de Bon Secours, Metz-Thionville, France
26Hematology department, Centre Henri Becquerel, Rouen, France
27Hopital La Source-CHR Orléans, Service d'Hématologie, Orleans, FRA
28Hematologie clinique, Limoges, FRA
29IUCT ONCOPOLE, Toulouse, FRA
30IUCT-Oncopole, Toulouse, France

10:00 AM

Muzaffar H. Qazilbash, MD 1, Qaiser Bashir, MD, MBBS2, Peter F Thall3*, Denái R. Milton4*, Nina Shah, MD5, Krina K. Patel, MD, MSc6, Borje S Andersson, MD, PhD7, Yago Nieto, MD, PhD8*, Partow Kebriaei, MD9, Benigno C. Valdez, PhD9, Jitesh Kawedia, BPharm10*, Simrit Parmar, MBBS11, Ruby Delgado9*, Sairah Ahmed, MD7, Chitra Hosing, MD8, Uday Popat, MD12, Elizabeth J. Shpall, MD13, Donna M. Weber, MD14, Sheeba K. Thomas, MD15, Elisabet E. Manasanch, MD16, Hans C. Lee, MD14, Robert Z. Orlowski, MD, PhD14 and Richard E Champlin, MD7

1Stem Cell Transplantation and Cellular Therapy, UT M.D. Anderson Cancer Ctr., Houston, TX
2Stem Cell Transplantation & Cellular Therapy, UT MD Anderson Cancer Center, Houston, TX
3The University of Texas MD Anderson Cancer Center, Houston, TX
4Department of Biostatistics, UT MD Anderson Cancer Center, Houston, TX
5400 Parnassus Ave, 4th floor, University of California San Francisco, San Francisco, CA
6Department of Lymphoma/Myeloma, UT MD Anderson Cancer Center, Houston, TX
7Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
8Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX
9Stem Cell Transplantation and Cellular Therapy, UT MD Anderson Cancer Center, Houston, TX
10UT MD Anderson Cancer Center, Houston, TX
11Stem Cell Transplantation, MD Anderson Cancer Center, Houston, TX
12Stem Cell Transplantation and Cellular Therapy, University of Texas M. D. Anderson Cancer Center, Houston, TX
13Stem Cell Transplantation and Cellular Therapy Department, The University of Texas MD Anderson Cancer Center, Houston, TX
14Lymphoma and Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX
15Lymphoma/Myeloma, UT MD Anderson Cancer Center, Houston, TX
16Department of Lymphoma and Myeloma, UT MD Anderson Cancer Center, Houston, TX

10:15 AM

Hartmut Goldschmidt, MD 1,2, Elias K Mai, MD1*, Jan Dürig, MD3*, Christof Scheid, MD4, Katja Weisel5*, Christina Kunz6*, Uta Bertsch, MD1,2*, Thomas Hielscher, PhD7*, Markus Munder, MD8*, Hans-Walter Lindemann9*, Barbara Huegle-Doerr1*, Dirk Hose, MD1, Anja Seckinger1, Stefanie Huhn, PhD1*, Anna Jauch10*, Bernhard Rabold11*, Ahmet Elmaagacli, MD12*, Christian Gerecke, MD13*, Peter Brossart, MD14*, Martin Goerner, MD15*, Helga Bernhard, MD16*, Martin Hoffmann, MD17*, Jens Hillengass, MD18, Marc-Steffen S Raab1*, Igor Wolfgang Blau, MD19*, Mathias Hänel, MD20* and Hans Jürgen Salwender21*

1Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany
2National Center for Tumor Diseases Heidelberg, Heidelberg, Germany
3Department of Hematology, University Hospital Essen, Essen, Germany
4Department of Internal Medicine I, University Hospital Cologne, Cologne, Germany
5Department of Hematology, Oncology and Immunology, University Hospital Tuebingen, Tuebingen, Germany
6Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany
7German Cancer Research Center (DKFZ), Heidelberg, Germany
8Department of Internal Medicine III, University Medical Center Mainz, Mainz, Germany
9Department of Hematology and Oncology, Katholisches Krankenhaus Hagen, Hagen, Germany
10Institute for Human Genetics, Heidelberg University Hospital, Heidelberg, Germany
11Coordination Center for Clinical Trials, University Hospital Heidelberg, Heidelberg, Germany
12Asklepios Hospital St. Georg, Hamburg, Germany
13Department of Hematology and Oncology, Helios Hospital Berlin-Buch, Berlin, Germany
14University Hospital Bonn, Bonn, Germany
15Department of Hematology, Oncology & Palliative Care, Hospital Bielefeld, Bielefeld, Germany
16Internal Medicine V, Klinikum Darmstadt, Darmstadt, Germany
17Medical Department A, Ludwigshafen Hospital, Ludwigshafen, Germany
18Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany
19Medical Department, Division of Hematology, Oncology, and Tumor Immunology, Charité Universitätsmedizin, Berlin, Germany
20Department of Internal Medicine III, Klinikum Chemnitz, Chemnitz, Germany
21Department of Hematology and Oncology, Asklepios Hospital Hamburg Altona, Hamburg, Germany

10:30 AM

Michele Cavo, MD1*, Francesca Maria Gay2*, Francesca Patriarca, MD3*, Elena Zamagni, MD4*, Vittorio Montefusco, MD5*, Luca Dozza1*, Monica Galli, MD, PhD6*, Sara Bringhen7*, Nicoletta Testoni, BSc1*, Mariella Grasso, MD8*, Stelvio Ballanti, MD9*, Paola Tacchetti, MD1*, Giampietro Semenzato, MD10*, Anna Marina Liberati11*, Giulia Benevolo12*, Mauro Spriano, MD13*, Paolo Di Bartolomeo, M.D14, Tommaso Caravita di Toritto, MD15*, Angelo D. Palmas, MD16, Anna Maria Cafro, MD17*, Fortunato Morabito, MD18*, Pellegrino Musto, MD19, Rita Rizzi, MD20*, Antonio Palumbo, MD21 and Pieter Sonneveld, MD, PhD22

1Seragnoli Institute of Hematology, Bologna University School of Medicine, Bologna, Italy
2Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliera Città della Salute e della Scienza di Torino, Torino, Italy
3Hematology, DAME, University of Udine, Udine, Italy
4Bologna University School of Medicine, Bologna, Italy
5Division of Hematology and Bone MarrowTransplant, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
6Hematology and Bone Marrow Transplant Unit, ASST Papa Giovanni XXIII, Bergamo, Italy
7Myeloma Unit, Division of Hematology, University of Torino, Torino, Italy
8Divisione di Ematologia, Ospedale Civico S. Croce e Carle, Cuneo, Italy
9Ospedale S. Maria della Misericordia, University of Perugia, Perugia, Italy
10Department of Medicine, Hematology and Clinical Immunology Section, Padua University School of Medicine, Padova, Italy
11University of Perugia, Azienda Ospedaliera S. Maria, Terni, Italy
12Division of Hematology, AOU Città della Salute e della Scienza, Torino, Italy
13Azienda Ospedaliera Universitaria S. Martino, Genova, Italy
14Department of Hematology, Transfusion Medicine and Biotecnology, " Spirito Santo " Civic Hospital, Pescara, Italy
15Ospedale S.Eugenio Roma, Roma, Italy
16Hematology, Ospedale San Francesco, Nuoro, ITA
17Department of Oncology/Hematology, Niguarda Ca' Granda Hospital, Milan, Italy
18Hematology Unit, Department of Hemato-Oncology, Annunziata Hospital Cosenza, Cosenza, Italy
19IRCCS, Centro Di Riferimento Oncologico Della Basilicata, Rionero in Vulture, Italy
20Medicina Interna e Oncologia Clinica, Policlinico di Bari, Bari, Italy
21University of Torino, Azienda Ospedaliera Città della Salute e della Scienza di Torino, Torino, Italy
22Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands

10:45 AM

Maria-Victoria Mateos, MD, PhD1, Joaquin Martinez Lopez2*, Paula Rodriguez-Otero, MD, PhD3*, Enrique M Ocio, MD4*, Marta Sonia Gonzalez, MD5*, Albert Oriol, MD6*, Norma Gutierrez, MD, PhD7*, Bruno Paiva, PhD8*, Rafael Rios9*, Laura Rosinol, MD, PhD10*, Miguel Angel Alvarez, MD11*, Maria Jose Calasanz, BSc, PhD12*, Joan Bargay, MD, PhD13*, Ana Pilar Gonzalez, PhD14*, Fernando Escalante, Dr.15*, Rafael Martínez16*, Noemi Puig, MD, PhD17*, Javier de la Rubia, MD18*, Ana Isabel Teruel, MD19*, Maria Teresa Teresa Cedena Romero20*, Felipe De Arriba, PhD21*, Luis Palomera22*, Miguel T Hernández23*, Javier Lopez Jimenez24*, Jesús Martín25*, Esther Piensa26*, Aránzazu García-Mateo27*, Veronica González17*, Joan Blade, MD28, Juan Jose Lahuerta29* and Jesus F. San Miguel, MD30

1University Hospital of Salamanca, Salamanca, Spain
2Hospital Universitario 12 de Octubre, Madrid, Spain
3University Clinic of Navarra, Center for Applied Medical Research (CIMA), IDISNA, Pamplona, Spain
4Hospital Clinico Universitario de Salamanca, Salamanca, Spain
5Hospital Universitario de Santiago, Santiago de Compostela, Spain
6ICO Badalona, Hospital Germans Trias i Pujol, Badalona, Spain
7IBSAL, University Hospital of Salamanca, Salamanca, Spain
8Universidad de Navarra, Pamplona, Spain
9Hospital Universitario Virgen de las Nieves de Granada, Granada, Spain
10Hospital Clinic i Provincial, Barcelona, Spain
11Hospital Universitario Reina Sofia, Cordoba, Spain
12Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada (CIMA), IDISNA, CIBERONC, Pamplona, Spain
13Hospital Sont LLatzer, Palma de Mallorca, Spain
14Hospital Central de Asturias, Oviedo, Spain
15Hospital Universitario de León, León, Spain
16Hospital Clínico San Carlos, Madrid, Spain
17IBSAL, Hospital Universitario de Salamanca, Salamanca, Spain
18Hematology Department, Universidad Católica de Valencia Hospital Dr. Peset, Valencia, Spain
19Hospital Clinico Universitario de Valencia, Valencia, Spain
20Hospital 12 de Octubre, Madrid, Spain
21Hospital Morales Meseguer, Murcia, Spain
22Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain
23Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain
24Hospital Ramon y Cajal, Madrid, Spain
25Hospital Universitario Virgen del Rocío, Sevilla, Spain
26Hospital de Mataró, Barcelona, Spain
27Hospital General de Segovia, Segovia, Spain
28Servicio de Onco-Hematología, Hospital Clínica de Barcelona, Barcelona, Spain
29Department of Hematology, Hospital 12 de Octubre, Madrid, Spain
30Centro de Investigación Médica Aplicada, University of Navarra, Clinica Universidad de Navarra, Pamplona, Spain

*signifies non-member of ASH